This observational study will evaluate the long-term efficacy and safety of RoActemra/Actemra (tocilizumab in participants of the ACT SURE clinical trial and further patients with moderate to severe rheumatoid arthritis starting or receiving RoActemra/Actemra. Data will be collected from each patient for up to 4 years.
Read more: http://www.clinicaltrials.gov/ct2/show/NCT01483326?cond=%22Arthritis%22&lup_s=10/31/2013&lup_d=30
